Richmond Pharmacology is excited to join the Gene Therapy Forum 23-25 March 2026 in Boston, USA.

This dedicated forum brings together leaders in gene therapy research, clinical development, biotechnology, regulation, and manufacturing to explore the latest advances in genetic medicine and the translation of innovative therapies into the clinic.

Representing Richmond Pharmacology:

  • Dr Jörg Taubel, Chief Executive Officer

Our Focus at the Forum

  • Advances in gene therapy platforms and delivery technologies
  • Clinical translation strategies for next‑generation genetic medicines
  • Safety, regulatory, and manufacturing considerations
  • Designing early‑phase and first‑in‑human gene therapy trials
  • Strengthening partnerships across academia, biotech, and clinical research

Connect With Us

If you are attending the Gene Therapy Forum 2026 and would like to explore collaboration or development opportunities:

📧 fasteranswers@richmondpharmacology.com

Find out more here: Gene Therapy Forum Conference

Latest news

Leadership Spotlight- Head of Pharmacy

June 25, 2026
In this edition, we spotlight Konrad Wieczorek, who leads Pharmacy
Read more

Upcoming Event

ESC Congress 2026

28 - 31 August 2026
Richmond Pharmacology is pleased to attend the ESC Congress 2026 in Munich, Germany, on 28 - 31 August 2026.
View event